The role of contrast-enhanced ultrasonography (CEUS) in comparison with (99m)Technetium-sestamibi scintigraphy for localization diagnostic of primary hyperparathyroidism

Agha, Ayman and Hornung, Matthias and Schlitt, Hans J. and Stroszczynski, Christian and Jung, Ernst-Michael (2014) The role of contrast-enhanced ultrasonography (CEUS) in comparison with (99m)Technetium-sestamibi scintigraphy for localization diagnostic of primary hyperparathyroidism. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 58 (4). pp. 515-520. ISSN 1386-0291, 1875-8622

Full text not available from this repository. (Request a copy)

Abstract

INTRODUCTION: Correct preoperative detection of parathyroid gland adenoma (PA) in the case of primary hyperparathyroidism (pHPT) is the requirement for unilateral cervical exploration associated with lower morbidity. We present our experience with contrast-enhanced ultrasonography (CEUS) as diagnostic tool for the preoperative localization of PA in pHPT in comparison to the (99m)Technetium-sestamibi scintigraphy. METHODS: Between 8/ 2009-5/ 2013 143 patients with pHPT received surgical interventions in the Department of Surgery at the University Hospital of Regensburg. In all patients contrast-enhanced ultrasonography (CEUS) was performed as diagnostic tool for the localization of pathological parathyroid glands. By one experienced examiner CEUS was performed after bolus injection of 1-2.4 ml contrast agent with storage of digital cine loops from the arterial phase (15-45 s) to the late phase (3 Min). Criteria for a parathyroid adenoma were marginal hypervascularisation in the arterial phase and wash out in the late phase. 74 patients received (99m)Technetium-sestamibi scintigraphy. The sensitivity of both diagnostic tools was analyzed in comparison to the intraoperative and histological findings. RESULTS: CEUS revealed a sensitivity of 95.9% for the detection of pathological parathyroid glands and even of 97.1% for patients without scintigrapy in comparison to 60.8% for (99m)Technetium-sestamibi scintigraphy. Sensitivity of CEUS in patients with negative scintigraphy was 96.3%. In multivariate regression analysis detection of small PA compared to scintigraphy was better by trend but did not reach significance (p = 0.019). Follow-up with a minimum of 8 weeks showed normal serum levels of calcium and parathyroid hormone in all patients except one. CONCLUSIONS: CEUS represents a new diagnostic method for the localization of parathyroid gland adenomas independent on findings in scintigraphy. In the present of appropriate expertise in CEUS no further diagnostic procedures are required.

Item Type: Article
Uncontrolled Keywords: PATHOLOGICAL PARATHYROID-GLANDS; PREOPERATIVE LOCALIZATION; ADENOMAS; SPECT/CT; ULTRASOUND; IMPACT; Contrast-enhanced ultrasonography; (99m)Technetium-sestamibi scintigraphy; diagnostic of primary hyperparathyroidism
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Medicine > Lehrstuhl für Röntgendiagnostik
Depositing User: Dr. Gernot Deinzer
Date Deposited: 28 Nov 2019 11:10
Last Modified: 28 Nov 2019 11:10
URI: https://pred.uni-regensburg.de/id/eprint/10864

Actions (login required)

View Item View Item